Trastuzumab/Deruxtecan

CHEBI:CHEBI_747667

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

listing_expiration_date
20251231
dosage_form
LIQUID
active_ingredient_strength
20 mg/mL
marketing_start_date
20221003
product_type
DRUG FOR FURTHER PROCESSING
marketing_category
DRUG FOR FURTHER PROCESSING
labeler_name
Lonza AG
generic_name
Trastuzumab/Deruxtecan
product_ndc
49187-0224
spl_id
1bde4467-e5d6-736b-e063-6394a90a49e6
active_ingredient_name
TRASTUZUMAB DERUXTECAN
package_ndc
49187-0224-1
package_description
12000 mL in 1 BAG (49187-0224-1)
package_marketing_start_date
03-OCT-22
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class